Sat, Oct 25, 2014, 12:06 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Nanosphere, Inc. (NSPH) Message Board

  • ilygod ilygod Feb 26, 2010 3:29 PM Flag

    Credit Suisse has outperform

    earnings results were not great.

    that said, the future diagnostic testing should add increasing revenue. NSPH with their troponin testing will be looked at for buyout by a larger company.

    time to accumulate at these levels. too many catalyst in the future.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • By the way, why would a larger company want to acquire NSPH if nobody is buying the tests they have? After all, even with the multiple FDA-cleared tests they have they can barely scrape together enough buyers to generate $1M in product revenues.

      • 2 Replies to sammyjammin
      • RE: acquisition - that is an excellent point you raised. If sales demonstrated a pattern of strong growth, or they were offering unique products/tests that had no competitors (e.g. GENZ) or the performance was better than the competition: faster, more sensitive/accurate, then they MIGHT be an attractive acquisition target. But NSPH is in none of the positions, and they have no impact on the customer base due their low sales and placement numbers. Sure they broadly own their IP space, but if performance isn't better, they would not be an attractive acquisition target (IMHO). Others can say we are trashing the stock, but these are NSPH and the FDA's figures - so why are we labeled as trashers?

      • excellent concerns cited. sales force may be one issue. two, pipeline of FDA approved products makes the company more attract from acquisition proposition. three, you can't always look to the past performance and predict the future.

        the trend is down for sure. so, give me your shares and i'll sell them back to you at $5+.

    • And once again one of the irrational pumpers on this board is kind enough to point out Credit Suisse's "guess" from two years ago about the pps....yet everything Credit Suisse predicted about this company has turned out to be false proselytizing.

    • keep eating those mushrooms! you might have better luck finding a pot of gold at the end of the rainbow!

 
NSPH
0.515+0.015(+2.98%)Oct 24 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.